Skip to content

mRNA HIV vaccine achieves 97 percent efficacy in George Washington School of Medicine and Health Sciences human trials

People in this story

George Washington Hatchet, January 2023

The George Washington School of Medicine and Health Sciences achieved a 97 percent success rate after conducting the first-ever human trials of the mRNA HIV vaccine over the past year, according to a release the school issued last month.

Researchers created a molecule inside the vaccine that elicits a response from bnAb precursor B cells, which eventually turn into cells that produce bnAbs – neutralizing antibodies that target the HIV virus, according to the study’s release. David Diemert, the clinical director of the GW Vaccine Research Unit, said in the release that the trials produced an efficacy rate that is more than 66 percent higher than any other HIV vaccine that has been tested on humans.

Continue reading at The George Washington Hatchet.

More Stories

Picture of Dasani water bottles.

Gov. Healey to sign order banning single-use plastic bottles for state agencies

Co-founder Andrew Song of solar geoengineering startup Make Sunsets holds a weather balloon filled with helium, air and sulfur dioxide at a park in Reno, Nevada, United States on February 12, 2023.

Some Politicians Want to Research Geoengineering as a Climate Solution. Scientists Are Worried

Plastics and other trash littered a salt marsh in Chelsea in April.

Massachusetts lags on banning plastics